A new cannabinoid study published recently in the Journal of Neuroimmune Pharmacology indicates that certain compounds in marijuana could help prevent Multiple Sclerosis (MS).
The study found that the presence of either of two cannabinoids found in marijuana, cannabidiol (CBD) or tetrahydrocannabinol (THC), regulates inflammation associated with MS by keeping the body’s cells from triggering an attack.
The presence of CBD or THC restrains the immune cells from triggering the production of inflammatory molecules, and limits the molecules’ ability to reach and damage the brain and spinal cord
Two other studies conducted in 2011 found that CBD helps treat the symptoms of MS in mice by preventing immune cells from attacking nerve cells in the spinal cord. In one of the studies, mice who suffered from symptoms of Multiple Sclerosis were treated with CBD and went from being partially paralyzed to walking with a limp.